Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2069209rdf:typepubmed:Citationlld:pubmed
pubmed-article:2069209lifeskim:mentionsumls-concept:C0019247lld:lifeskim
pubmed-article:2069209lifeskim:mentionsumls-concept:C0018787lld:lifeskim
pubmed-article:2069209lifeskim:mentionsumls-concept:C1333178lld:lifeskim
pubmed-article:2069209lifeskim:mentionsumls-concept:C0006141lld:lifeskim
pubmed-article:2069209lifeskim:mentionsumls-concept:C0206650lld:lifeskim
pubmed-article:2069209lifeskim:mentionsumls-concept:C0004083lld:lifeskim
pubmed-article:2069209lifeskim:mentionsumls-concept:C0332257lld:lifeskim
pubmed-article:2069209lifeskim:mentionsumls-concept:C0348080lld:lifeskim
pubmed-article:2069209lifeskim:mentionsumls-concept:C0205295lld:lifeskim
pubmed-article:2069209pubmed:issue8lld:pubmed
pubmed-article:2069209pubmed:dateCreated1991-8-15lld:pubmed
pubmed-article:2069209pubmed:abstractTextAmong 145 patients with the complex of myxomas, spotty pigmentation, endocrine overactivity, and psammomatous melanotic schwannomas, 31 (21%) had mammary lesions. The ages of these 26 females and five males ranged from 6 to 64 years (mean, 30 years). Five patients had breast symptoms. In 21 (81%) of the females, benign mesenchymal lesion(s) were detected pathologically. These were characterized by accumulations of large amounts of ground substance in the lobules that alterated the stroma to a very loose and myxoid tissue. The change involved single lobules (lobular myxoid change), small groups of lobules (nodular myxoid change), and large aggregates of lobules (myxoid fibroadenoma); the interlobular stroma was affected to a lesser degree. The lesions were multicentric and bilateral in eight patients (38%). Because the myxoid breast lesions were familial, were frequent findings in the complex, and were similar histologically to the cardiac and cutaneous myxomas in the complex, they undoubtedly are a component and a pathologic marker of the complex. They were the presenting feature of the complex in six patients (19%). Therefore, discovery of the myxoid breast lesions on pathologic examination should raise suspicion of the complex, and affected patients (and their primary relatives) should be evaluated accordingly.lld:pubmed
pubmed-article:2069209pubmed:languageenglld:pubmed
pubmed-article:2069209pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2069209pubmed:citationSubsetIMlld:pubmed
pubmed-article:2069209pubmed:statusMEDLINElld:pubmed
pubmed-article:2069209pubmed:monthAuglld:pubmed
pubmed-article:2069209pubmed:issn0147-5185lld:pubmed
pubmed-article:2069209pubmed:authorpubmed-author:CarneyJ AJAlld:pubmed
pubmed-article:2069209pubmed:authorpubmed-author:ToorkeyB CBClld:pubmed
pubmed-article:2069209pubmed:issnTypePrintlld:pubmed
pubmed-article:2069209pubmed:volume15lld:pubmed
pubmed-article:2069209pubmed:ownerNLMlld:pubmed
pubmed-article:2069209pubmed:authorsCompleteYlld:pubmed
pubmed-article:2069209pubmed:pagination713-21lld:pubmed
pubmed-article:2069209pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:2069209pubmed:meshHeadingpubmed-meshheading:2069209-...lld:pubmed
pubmed-article:2069209pubmed:meshHeadingpubmed-meshheading:2069209-...lld:pubmed
pubmed-article:2069209pubmed:meshHeadingpubmed-meshheading:2069209-...lld:pubmed
pubmed-article:2069209pubmed:meshHeadingpubmed-meshheading:2069209-...lld:pubmed
pubmed-article:2069209pubmed:meshHeadingpubmed-meshheading:2069209-...lld:pubmed
pubmed-article:2069209pubmed:meshHeadingpubmed-meshheading:2069209-...lld:pubmed
pubmed-article:2069209pubmed:meshHeadingpubmed-meshheading:2069209-...lld:pubmed
pubmed-article:2069209pubmed:meshHeadingpubmed-meshheading:2069209-...lld:pubmed
pubmed-article:2069209pubmed:meshHeadingpubmed-meshheading:2069209-...lld:pubmed
pubmed-article:2069209pubmed:meshHeadingpubmed-meshheading:2069209-...lld:pubmed
pubmed-article:2069209pubmed:meshHeadingpubmed-meshheading:2069209-...lld:pubmed
pubmed-article:2069209pubmed:meshHeadingpubmed-meshheading:2069209-...lld:pubmed
pubmed-article:2069209pubmed:meshHeadingpubmed-meshheading:2069209-...lld:pubmed
pubmed-article:2069209pubmed:meshHeadingpubmed-meshheading:2069209-...lld:pubmed
pubmed-article:2069209pubmed:meshHeadingpubmed-meshheading:2069209-...lld:pubmed
pubmed-article:2069209pubmed:meshHeadingpubmed-meshheading:2069209-...lld:pubmed
pubmed-article:2069209pubmed:meshHeadingpubmed-meshheading:2069209-...lld:pubmed
pubmed-article:2069209pubmed:meshHeadingpubmed-meshheading:2069209-...lld:pubmed
pubmed-article:2069209pubmed:meshHeadingpubmed-meshheading:2069209-...lld:pubmed
pubmed-article:2069209pubmed:meshHeadingpubmed-meshheading:2069209-...lld:pubmed
pubmed-article:2069209pubmed:meshHeadingpubmed-meshheading:2069209-...lld:pubmed
pubmed-article:2069209pubmed:year1991lld:pubmed
pubmed-article:2069209pubmed:articleTitleMyxoid fibroadenoma and allied conditions (myxomatosis) of the breast. A heritable disorder with special associations including cardiac and cutaneous myxomas.lld:pubmed
pubmed-article:2069209pubmed:affiliationSection of Surgical Pathology, Mayo Clinic, Rochester, MN 55905.lld:pubmed
pubmed-article:2069209pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2069209lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2069209lld:pubmed